BIOCRYST PHARMACEUTICALS, INC. Net Income
BIOCRYST PHARMACEUTICALS, INC. (BCRX) reported Net Income of $78.39 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement
us-gaap:NetIncomeLoss · last filed 2026-08-05
- BIOCRYST PHARMACEUTICALS, INC. net income (loss) attributable to parent for the quarter ending 2026-06-30 was $78.39M, a 1441.69% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$721.81M, a 2255762.50% decline year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. net income (loss) attributable to parent for the quarter ending 2025-12-31 was $245.84M.
- BIOCRYST PHARMACEUTICALS, INC. net income (loss) attributable to parent for the quarter ending 2025-09-30 was $12.90M.
- BIOCRYST PHARMACEUTICALS, INC. net income (loss) attributable to parent for fiscal 2020 was -$182.81M.
- BIOCRYST PHARMACEUTICALS, INC. net income (loss) attributable to parent for fiscal 2019 was -$108.90M.
- BIOCRYST PHARMACEUTICALS, INC. net income (loss) attributable to parent for fiscal 2018 was -$101.25M.
- BIOCRYST PHARMACEUTICALS, INC. net income (loss) attributable to parent for fiscal 2017 was -$65.78M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | $78.39M 10-Q · filed 2026-08-05 | -$643.42M 10-Q · filed 2026-08-05 | -$397.57M derived: sum of 3 quarters · filed 2026-08-05 | -$384.67M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$721.81M 10-Q · filed 2026-08-05 | -$475.97M derived: sum of 2 quarters · filed 2026-08-05 | -$463.07M derived: sum of 3 quarters · filed 2026-08-05 | -$457.98M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $245.84M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-23 | $258.74M derived: sum of 2 quarters · filed 2026-04-23 | $263.83M derived: sum of 3 quarters · filed 2026-08-05 | $263.86M DEF 14A · filed 2026-04-23 |
| 2025-09-30 | $12.90M 10-Q · filed 2025-11-04 | $17.98M derived: sum of 2 quarters · filed 2026-08-05 | $18.02M 10-Q · filed 2025-11-04 | -$8.78M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $5.08M 10-Q · filed 2026-08-05 | $5.12M 10-Q · filed 2026-08-05 | -$21.68M derived: sum of 3 quarters · filed 2026-08-05 | -$35.71M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $32.00K 10-Q · filed 2026-08-05 | -$26.76M derived: sum of 2 quarters · filed 2026-08-05 | -$40.80M derived: sum of 3 quarters · filed 2026-08-05 | -$53.47M derived: sum of 4 quarters · filed 2026-08-05 |
| 2024-12-31 | -$26.80M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-23 | -$40.83M derived: sum of 2 quarters · filed 2026-04-23 | -$53.50M derived: sum of 3 quarters · filed 2026-04-23 | -$88.88M DEF 14A · filed 2026-04-23 |
| 2024-09-30 | -$14.03M 10-Q · filed 2025-11-04 | -$26.71M derived: sum of 2 quarters · filed 2025-11-04 | -$62.09M 10-Q · filed 2025-11-04 | -$123.82M derived: sum of 4 quarters · filed 2026-04-23 |
| 2024-06-30 | -$12.67M 10-Q · filed 2025-11-04 | -$48.05M 10-Q · filed 2025-08-05 | -$109.78M derived: sum of 3 quarters · filed 2026-04-23 | -$145.93M derived: sum of 4 quarters · filed 2026-04-23 |
| 2024-03-31 | -$35.38M 10-Q · filed 2025-11-04 | -$97.11M derived: sum of 2 quarters · filed 2026-04-23 | -$133.26M derived: sum of 3 quarters · filed 2026-04-23 | -$208.59M derived: sum of 4 quarters · filed 2026-04-23 |
| 2023-12-31 | -$61.73M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-23 | -$97.88M derived: sum of 2 quarters · filed 2026-04-23 | -$173.21M derived: sum of 3 quarters · filed 2026-04-23 | -$226.54M DEF 14A · filed 2026-04-23 |
| 2023-09-30 | -$36.15M 10-Q · filed 2024-11-05 | -$111.47M derived: sum of 2 quarters · filed 2024-11-05 | -$164.81M 10-Q · filed 2024-11-05 | -$236.35M derived: sum of 4 quarters · filed 2026-04-23 |
| 2023-06-30 | -$75.33M 10-Q · filed 2024-11-05 | -$128.66M 10-Q · filed 2024-08-06 | -$200.20M derived: sum of 3 quarters · filed 2026-04-23 | -$242.72M derived: sum of 4 quarters · filed 2026-04-23 |
| 2023-03-31 | -$53.33M 10-Q · filed 2024-11-05 | -$124.87M derived: sum of 2 quarters · filed 2026-04-23 | -$167.39M derived: sum of 3 quarters · filed 2026-04-23 | -$226.25M derived: sum of 4 quarters · filed 2026-04-23 |
| 2022-12-31 | -$71.54M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-23 | -$114.06M derived: sum of 2 quarters · filed 2026-04-23 | -$172.92M derived: sum of 3 quarters · filed 2026-04-23 | -$247.12M DEF 14A · filed 2026-04-23 |
| 2022-09-30 | -$42.52M 10-Q · filed 2023-11-08 | -$101.38M derived: sum of 2 quarters · filed 2023-11-08 | -$175.57M 10-Q · filed 2023-11-08 | -$193.35M derived: sum of 4 quarters · filed 2026-04-23 |
| 2022-06-30 | -$58.86M 10-Q · filed 2023-11-08 | -$133.06M 10-Q · filed 2023-08-07 | -$150.83M derived: sum of 3 quarters · filed 2026-04-23 | -$209.63M derived: sum of 4 quarters · filed 2026-04-23 |
| 2022-03-31 | -$74.20M 10-Q · filed 2023-11-08 | -$91.97M derived: sum of 2 quarters · filed 2026-04-23 | -$150.78M derived: sum of 3 quarters · filed 2026-04-23 | -$193.97M derived: sum of 4 quarters · filed 2026-04-23 |
| 2021-12-31 | -$17.78M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-23 | -$76.58M derived: sum of 2 quarters · filed 2026-04-23 | -$119.78M derived: sum of 3 quarters · filed 2026-04-23 | -$184.06M DEF 14A · filed 2026-04-23 |
| 2021-09-30 | -$58.80M 10-Q · filed 2022-11-04 | -$102.00M derived: sum of 2 quarters · filed 2022-11-04 | -$166.28M 10-Q · filed 2022-11-04 | -$226.78M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | -$43.20M 10-Q · filed 2022-11-04 | -$107.48M 10-Q · filed 2022-08-05 | -$167.97M derived: sum of 3 quarters · filed 2022-11-04 | -$214.09M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-03-31 | -$64.28M 10-Q · filed 2022-11-04 | -$124.78M derived: sum of 2 quarters · filed 2022-11-04 | -$170.89M derived: sum of 3 quarters · filed 2022-11-04 | -$209.50M derived: sum of 4 quarters · filed 2022-11-04 |
| 2020-12-31 | -$60.49M 10-K · filed 2021-03-01 | -$106.61M derived: sum of 2 quarters · filed 2021-11-04 | -$145.22M derived: sum of 3 quarters · filed 2021-11-04 | -$182.81M 10-K · filed 2023-02-27 |
| 2020-09-30 | -$46.12M 10-Q · filed 2021-11-04 | -$84.72M derived: sum of 2 quarters · filed 2021-11-04 | -$122.32M 10-Q · filed 2021-11-04 | -$124.94M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | -$38.61M 10-Q · filed 2021-11-04 | -$76.21M 10-Q · filed 2021-08-09 | -$78.83M derived: sum of 3 quarters · filed 2021-11-04 | -$116.42M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-03-31 | -$37.60M 10-Q · filed 2021-11-04 | -$40.22M derived: sum of 2 quarters · filed 2021-11-04 | -$77.81M derived: sum of 3 quarters · filed 2021-11-04 | -$115.44M derived: sum of 4 quarters · filed 2021-11-04 |
| 2019-12-31 | -$2.62M 10-K · filed 2021-03-01 | -$40.21M derived: sum of 2 quarters · filed 2021-03-01 | -$77.84M derived: sum of 3 quarters · filed 2021-03-01 | -$108.90M 10-K · filed 2022-02-28 |
| 2019-09-30 | -$37.59M 10-K · filed 2021-03-01 | -$75.22M derived: sum of 2 quarters · filed 2021-03-01 | -$106.28M 10-Q · filed 2020-11-06 | -$133.71M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | -$37.63M 10-K · filed 2021-03-01 | -$68.68M 10-Q · filed 2020-08-07 | -$96.11M derived: sum of 3 quarters · filed 2021-03-01 | -$125.71M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | -$31.05M 10-K · filed 2021-03-01 | -$58.49M derived: sum of 2 quarters · filed 2021-03-01 | -$88.08M derived: sum of 3 quarters · filed 2021-03-01 | -$106.53M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | -$27.43M 10-K · filed 2020-03-13 | -$57.03M derived: sum of 2 quarters · filed 2020-03-13 | -$75.47M derived: sum of 3 quarters · filed 2020-03-13 | -$101.25M 10-K · filed 2021-03-01 |
| 2018-09-30 | -$29.60M 10-K · filed 2020-03-13 | -$48.04M derived: sum of 2 quarters · filed 2020-03-13 | -$73.82M 10-Q · filed 2019-11-08 | -$93.36M derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-06-30 | -$18.45M 10-K · filed 2020-03-13 | -$44.22M 10-Q · filed 2019-08-08 | -$63.77M derived: sum of 3 quarters · filed 2020-03-13 | -$78.90M derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-03-31 | -$25.78M 10-K · filed 2020-03-13 | -$45.32M derived: sum of 2 quarters · filed 2020-03-13 | -$60.45M derived: sum of 3 quarters · filed 2020-03-13 | -$77.34M derived: sum of 4 quarters · filed 2020-03-13 |
| 2017-12-31 | -$19.54M 10-K · filed 2019-03-14 | -$34.68M derived: sum of 2 quarters · filed 2019-03-14 | -$51.56M derived: sum of 3 quarters · filed 2019-03-14 | -$65.78M 10-K · filed 2020-03-13 |
| 2017-09-30 | -$15.13M 10-K · filed 2019-03-14 | -$32.02M derived: sum of 2 quarters · filed 2019-03-14 | -$46.24M 10-Q · filed 2018-11-08 | -$50.74M derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-06-30 | -$16.89M 10-K · filed 2019-03-14 | -$31.11M 10-Q · filed 2018-08-09 | -$35.61M derived: sum of 3 quarters · filed 2019-03-14 | -$47.14M derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-03-31 | -$14.22M 10-K · filed 2019-03-14 | -$18.72M derived: sum of 2 quarters · filed 2019-03-14 | -$30.25M derived: sum of 3 quarters · filed 2019-03-14 | -$46.53M derived: sum of 4 quarters · filed 2019-03-14 |
| 2016-12-31 | -$4.50M 10-K · filed 2018-03-12 | -$16.03M derived: sum of 2 quarters · filed 2018-03-12 | -$32.31M derived: sum of 3 quarters · filed 2018-03-12 | -$55.14M 10-K · filed 2019-03-14 |
| 2016-09-30 | -$11.53M 10-K · filed 2018-03-12 | -$27.81M derived: sum of 2 quarters · filed 2018-03-12 | -$50.64M 10-Q · filed 2017-11-08 | -$68.78M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | -$16.28M 10-K · filed 2018-03-12 | -$39.11M 10-Q · filed 2017-08-08 | -$57.25M derived: sum of 3 quarters · filed 2018-03-12 | -$71.87M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | -$22.83M 10-K · filed 2018-03-12 | -$40.97M derived: sum of 2 quarters · filed 2018-03-12 | -$55.59M derived: sum of 3 quarters · filed 2018-03-12 | -$50.69M derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | -$18.14M 10-K · filed 2017-02-27 | -$32.76M derived: sum of 2 quarters · filed 2017-02-27 | -$27.86M derived: sum of 3 quarters · filed 2017-02-27 | -$43.02M 10-K · filed 2018-03-12 |
| 2015-09-30 | -$14.62M 10-K · filed 2017-02-27 | -$9.72M derived: sum of 2 quarters · filed 2017-02-27 | -$24.88M 10-Q · filed 2016-11-08 | -$36.56M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-06-30 | $4.90M 10-K · filed 2017-02-27 | -$10.26M 10-Q · filed 2016-08-08 | -$21.93M derived: sum of 3 quarters · filed 2017-02-27 | -$30.67M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-03-31 | -$15.16M 10-K · filed 2017-02-27 | -$26.84M derived: sum of 2 quarters · filed 2017-02-27 | -$35.57M derived: sum of 3 quarters · filed 2017-02-27 | -$50.22M derived: sum of 4 quarters · filed 2017-02-27 |
| 2014-12-31 | -$11.67M 10-K · filed 2016-02-26 | -$20.40M derived: sum of 2 quarters · filed 2016-02-26 | -$35.05M derived: sum of 3 quarters · filed 2016-02-26 | -$45.19M 10-K · filed 2017-02-27 |
| 2014-09-30 | -$8.73M 10-K · filed 2016-02-26 | -$23.38M derived: sum of 2 quarters · filed 2016-02-26 | -$33.52M 10-Q · filed 2015-11-06 | -$38.95M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | -$14.65M 10-K · filed 2016-02-26 | -$24.79M 10-Q · filed 2015-08-07 | -$30.21M derived: sum of 3 quarters · filed 2016-02-26 | -$38.22M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | -$10.14M 10-K · filed 2016-02-26 | -$15.57M derived: sum of 2 quarters · filed 2016-02-26 | -$23.57M derived: sum of 3 quarters · filed 2016-02-26 | -$35.74M derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | -$5.43M 10-K · filed 2015-03-02 | -$13.43M derived: sum of 2 quarters · filed 2015-03-02 | -$25.60M derived: sum of 3 quarters · filed 2015-03-02 | -$30.11M 10-K · filed 2016-02-26 |
| 2013-09-30 | -$8.00M 10-K · filed 2015-03-02 | -$20.17M derived: sum of 2 quarters · filed 2015-03-02 | -$24.68M 10-Q · filed 2014-11-07 | -$35.73M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | -$12.17M 10-K · filed 2015-03-02 | -$16.68M 10-Q · filed 2014-08-08 | -$27.73M derived: sum of 3 quarters · filed 2015-03-02 | -$37.43M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | -$4.51M 10-K · filed 2015-03-02 | -$15.56M derived: sum of 2 quarters · filed 2015-03-02 | -$25.26M derived: sum of 3 quarters · filed 2015-03-02 | -$37.53M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | -$11.05M 10-K · filed 2014-03-10 | -$20.75M derived: sum of 2 quarters · filed 2014-03-10 | -$33.03M derived: sum of 3 quarters · filed 2014-03-10 | -$39.08M 10-K · filed 2015-03-02 |
| 2012-09-30 | -$9.70M 10-K · filed 2014-03-10 | -$21.98M derived: sum of 2 quarters · filed 2014-03-10 | -$28.03M 10-Q · filed 2013-11-08 | -$41.22M derived: sum of 4 quarters · filed 2014-03-10 |
| 2012-06-30 | -$12.28M 10-K · filed 2014-03-10 | -$18.33M 10-Q · filed 2013-08-08 | -$31.52M derived: sum of 3 quarters · filed 2014-03-10 | -$45.98M derived: sum of 4 quarters · filed 2014-03-10 |
| 2012-03-31 | -$6.05M 10-K · filed 2014-03-10 | -$19.24M derived: sum of 2 quarters · filed 2014-03-10 | -$33.70M derived: sum of 3 quarters · filed 2014-03-10 | -$49.97M derived: sum of 4 quarters · filed 2014-03-10 |
| 2011-12-31 | -$13.19M 10-K · filed 2013-03-11 | -$27.65M derived: sum of 2 quarters · filed 2013-03-11 | -$43.92M derived: sum of 3 quarters · filed 2013-03-11 | -$56.95M 10-K · filed 2014-03-10 |
| 2011-09-30 | -$14.46M 10-K · filed 2013-03-11 | -$30.73M derived: sum of 2 quarters · filed 2013-03-11 | -$43.76M 10-Q · filed 2012-11-08 | -$53.96M derived: sum of 4 quarters · filed 2013-03-11 |
| 2011-06-30 | -$16.27M 10-K · filed 2013-03-11 | -$29.30M 10-Q · filed 2012-08-08 | -$39.50M derived: sum of 3 quarters · filed 2013-03-11 | -$50.36M derived: sum of 4 quarters · filed 2013-03-11 |
| 2011-03-31 | -$13.03M 10-K · filed 2013-03-11 | -$23.23M derived: sum of 2 quarters · filed 2013-03-11 | -$34.09M derived: sum of 3 quarters · filed 2013-03-11 | -$44.28M derived: sum of 4 quarters · filed 2013-03-11 |
| 2010-12-31 | -$10.20M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | -$21.07M derived: sum of 2 quarters · filed 2013-03-11 | -$31.26M derived: sum of 3 quarters · filed 2013-03-11 | -$33.85M 10-K · filed 2013-03-11 |
| 2010-09-30 | -$10.86M 10-Q · filed 2011-11-03 | -$21.06M derived: sum of 2 quarters · filed 2011-11-03 | -$23.65M 10-Q · filed 2011-11-03 | |
| 2010-06-30 | -$10.19M 10-Q · filed 2011-08-04 | -$12.79M 10-Q · filed 2011-08-04 | ||
| 2009-12-31 | -$13.45M 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |